Skip to main content
. 2021 Apr 19;11(13):6334–6354. doi: 10.7150/thno.59342

Figure 3.

Figure 3

Nanocarriers can help transport therapeutic agents across a series of physiological barriers, thus successfully escaping from the reticuloendothelial system during blood circulation, completing EPR-mediated tumor accumulation, tumor microenvironmental delivery (the penetration of stromal barriers) and intracellular delivery (lysosomal escape, cytoplasmic release or organelle release). Reproduced with permission from Ref. 72, Copyright © 2017, Royal Society of Chemistry. Abbreviations: EPR: enhanced permeability and retention.